CLDX vs INTC · rev $37.0K vs rev $29.70B
Celldex Therapeutics Inc (CLDX) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
CLDX currently screens at market cap $2.35B. INTC currently screens at market cap $498.43B.
Not investment advice. Open the CLDX and INTC stock pages for the full models.
Not investment advice.